Provided by Tiger Fintech (Singapore) Pte. Ltd.

Roivant Sciences Ltd.

11.03
-0.1400-1.25%
Post-market: 11.030.00000.00%19:59 EDT
Volume:5.80M
Turnover:64.33M
Market Cap:7.87B
PE:-70.86
High:11.25
Open:11.16
Low:10.90
Close:11.17
Loading ...
Feb 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 13, 2024

Major Issues Report

Form 8-K - Current report
Feb 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 01, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 21, 2023

Major Issues Report

Form 8-K - Current report
Dec 20, 2023

Major Issues Report

Form 8-K/A - Current report: [Amend]
Dec 14, 2023

Major Issues Report

Form 8-K - Current report
Nov 30, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 28, 2023

Major Issues Report

Form 8-K - Current report
Nov 27, 2023

Major Issues Report

Form 8-K - Current report
Nov 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2023

Major Issues Report

Form 8-K - Current report
Oct 31, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 24, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 24, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 24, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities